Sort
1,049,261 grants matching “t cell”
Wyoming IDeA Networks for Biomedical Research Excellence Phase 4
$3,484,796Robert Scott Seville · University Of Wyoming · P20 · FY2020 · GM
Toward a comprehensive functional annotation of the human genome
$3,483,414Richard M Myers · Hudson-Alpha Institute For Biotechnology · U54 · FY2014 · HG
Membrane Remodeling in Viral Infection and Viral Assembly
$3,483,111Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Transplant Tolerance in Non-Human Primates
$3,480,972Christian P Larsen · Emory University · U19 · FY2014 · AI
Transplant Tolerance in Non-Human Primates
$3,480,971Christian P Larsen · Emory University · U19 · FY2016 · AI
Mechanisms of retinal degeneration in inherited diseases
$3,480,625Anand Swaroop · National Eye Institute · ZIA · FY2010 · EY
Identifying Relapse Predictors and Therapeutic Vulnerabilities in Ph+ and Ph-like Acute Lymphoblastic Leukemia
$3,480,276Mignon Lee-Cheun Loh · Seattle Children'S Hospital · R01 · FY2025 · CA
TAS::89 0321::TAS PHASE III XLERATOR PROGRAM- PHASE III XLERATOR PROGRAM BACKSIDE CONTACT MULTIJUNCTION SOLAR CELLS FOR HIGH CONCENTRATION APPLICATIO
$3,480,000Microlink Devices Inc · · FY2010 · Department of Energy
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$3,478,888Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah · U01 · FY2025 · NS
Human Biochemical Genetics
$3,478,846William Gahl · National Human Genome Research Institute · ZIA · FY2023 · HG
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines
$3,478,707Harriet L Robinson · Geovax, Inc. · U19 · FY2008 · AI
Project 5: Multi-scale development and evaluation of broadly-effective vaccines against picornaviruses with pandemic potential
$3,478,173Bert L. Semler · University Of California-Irvine · U19 · FY2024 · AI
The Therapy of CML
$3,477,908Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
Children's Oncology Group Chair's Grant
$3,476,591National Childhood Cancer Foundation · U10 · FY2005 · CA
RCT OF PLANT-BASED DIET IN BREAST CANCER RECURRENCE
$3,476,314University Of California San Diego · R01 · FY2005 · CA
Cardiovascular Genomics and Bioinformatics projects
$3,476,077Andrew Johnson · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Impact of ApoE2 on aging-related conditions
$3,476,050Takahisa Kanekiyo · Mayo Clinic Jacksonville · RF1 · FY2018 · AG
Pharmacology Core
$3,475,988Veronique Dartois · Hackensack University Medical Center · U19 · FY2022 · AI
The Adipocyte PPARgama/Adiponectin Axis and Alzheimer's Disease
$3,475,970Xin-Yun Lu · Augusta University · RF1 · FY2019 · AG
Development of an Effector-Memory T Cell AIDS Vaccine
$3,475,833Louis J. Picker · Oregon Health & Science University · P01 · FY2016 · AI
Genomic Analysis of Network Perturbations in Human Disease
$3,475,488Marc Vidal · Dana-Farber Cancer Inst · P50 · FY2011 · HG
Genetic epidemiology of complex diseases
$3,475,033Charles Rotimi · National Human Genome Research Institute · ZIA · FY2020 · HG
Evolution and Durability of Human T and B Cell Responses
$3,474,901Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2025 · AI
Evolution and Durability of Human T and B Cell Responses
$3,474,901Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2024 · AI
Sirtuins and nuclear receptors in aging and age-associated diseases
$3,474,264Xiaoling Li · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES